Results 71 to 80 of about 109,922 (297)

Treatment Trends of Myocarditis with Coxsackievirus B3 infection

Al-Mustansiriyah Journal of Pharmaceutical Sciences, 2020
Viral myocarditis occurred after viral invasion of the cardiocytes and followed by the releasing of viral particles and inflammatory cells. Acute viral myocarditis is relatively common phase of the disease cured spontaneously in some cases or leading to
Dalya Basil Hanna, Ghaith Ali Jasim, Arwa Mujahid Abdullah Al-Shuwaikh   +2 more
doaj   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Long-term effects on cardiac function and symptoms in patients with myocarditis following COVID-19 vaccination: the ECHOVID-19 Long-term Study

Open Heart
Background The long-term effects of myocarditis following COVID-19 vaccination on cardiac function and symptoms remain unclear.Purpose To assess the long-term effects of myocarditis following COVID-19 vaccination on cardiac function, inflammatory ...
Manan Pareek, Tor Biering-Sørensen, Anders Hviid, Filip Soeskov Davidovski, Kristoffer Grundtvig Skaarup, Mohammad Nizar Ramadan, Caroline Espersen, Ali Hikmat Al-Rubai, Ayat Khoraizat, Niklas Dyrby Johansen, Mats Christian Højbjerg Lassen, Tyra Grove   +11 more
doaj   +1 more source

Investigating pathological features of myocarditis-related sudden cardiac deaths in Egypt

Egyptian Journal of Forensic Sciences
Background Myocarditis is an inflammatory condition of the myocardium. A definitive diagnosis requires histopathological examination. The scarcity of autopsy data has led to this study, which analyzed the histopathological features of myocarditis-related
Nora Fnon, Asmaa Sharif, Hanan Hassan, Amal Hafez, Zahraa Sobh   +4 more
doaj   +1 more source

Prevalence of myocarditis in critically-ill pediatric patients in Qena University Hospital

SVU - International Journal of Medical Sciences
Background: Myocarditis is a potentially life-threatening inflammatory disease affecting the myocardium. There are many different etiologies, most of which are infectious. The spectrum of presentations can range between subclinical disease and congestive
Ahmed El-Abd Ahmed , Abdallah Elaiw Mohamed Ali , Heba Mohamed Qubasy , Mohamed Said Sami Saleh Younes *   +3 more
doaj   +1 more source

IMMUNOLOGICAL FEATURES OF INFLAMMATORY MYOCARDIAL DISEASES DUE TO VIRAL INFECTIONS

Alʹmanah Kliničeskoj Mediciny, 2016
Background: Autoantibodies to myocardial antigenic epitopes and corresponding autoreactive T cell clones play an important role in myocardial damage and in pathogenesis of infectious immune myocarditis.
F. N. Paleev, N. P. Sanina, A. I. Makarkov, N. M. Mylov, E. I. Ostrovskiy, N. N. Khishova, O. V. Moskalets, N. R. Paleev   +7 more
doaj   +1 more source

Opioid-Induced Immunomodulation: Consequences for the Experimental Coxsackievirus B3-Induced Myocarditis Model

Biology, 2020
Myocarditis is an inflammatory disorder of the heart predominantly caused by infectious agents. Since more than sixty years, the Coxsackievirus B3 (CVB3)-induced myocarditis mouse model is the experimental model used to investigate viral myocarditis. The
Kathleen Pappritz, Sophie Van Linthout
doaj   +1 more source

Rheumatic Myocarditis [PDF]

The American Journal of the Medical Sciences, 1909
n ...
openaire   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer, 2019
Background Influenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibitors
Anju Nohria, Stephane Ederhy, Franck Thuny, Michael Mahmoudi, Alexander R. Lyon, Ryan J. Sullivan, Javid J. Moslehi, Justine V. Cohen, Magid Awadalla, Doll Lauren Alexandra Golden, Syed S. Mahmood, Raza M. Alvi, Nathaniel D. Mercaldo, Malek Z. O. Hassan, Dahlia Banerji, Adam Rokicki, Connor Mulligan, Sean P. T. Murphy, Maeve Jones-O’Connor, Lucie M. Heinzerling, Merna Armanious, Rongras Damrongwatanasuk, Carol L. Chen, Dipti Gupta, Michael C. Kirchberger, Sachin P. Shah, Sarju Ganatra, Paaladinesh Thavendiranathan, Muhammad A. Rizvi, Gagan Sahni, Carlo G. Tocchetti, Valentina Mercurio, Donald P. Lawrence, John D. Groarke, Michael G. Fradley, Kerry L. Reynolds, Tomas G. Neilan   +36 more
doaj   +1 more source